Systemic lupus erythematosus (SLE) is an autoimmune disease that sometimes involves the central nervous system in a condition known as neuropsychiatric SLE (NPSLE). Research in mice has shown that ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

An important characteristic of immune system activation in SLE is the presence of increased circulating levels of IFN-α, which correlate with disease activity and the occurrence of specific ...

Pharmaceutical Executive: What preclinical or early clinical data supports the concept of an 'immune reset' in SLE/LN, and what are you tracking in trials to assess the potential for achieving this?

A study conducted by researchers from São Paulo State University (UNESP), in Brazil, and collaborators shows that lemon ...

Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help neutralize and eliminate diseas | Immunology ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and ...

The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.